Beside the genes, which were described earlier as possible targets of epigenetic silencing in gliomas (SFRP1, SFRP2, DKK1), the methylation of PPP2R2B, SOX17, and DACH1 was also assessed. Here, SOX17 is linked to central nervous system cancer.